MYC and cancer: Moreover, because GFI1 can modulate the levels of specific bioactive lipid components that can modify cancer cell fate, this suggests that targeting GFI1 may also provide a new therapeutic approach for other types of aggressive cancers expressing high levels of c-Myc.